Low molecular weight heparin or semuloparin should not be recommended for thromboprophylaxis in ambulatory solid cancer patients undergoing chemotherapy
Oo, Thein H.Volume:
130
Language:
english
Journal:
Thrombosis Research
DOI:
10.1016/j.thromres.2012.07.026
Date:
November, 2012
File:
PDF, 113 KB
english, 2012